Navigation Links
New uses for imidazolium salts in medicine and alternative energy
Date:12/2/2008

Scientists at Singapore's Institute of Bioengineering and Nanotechnology (IBN) have uncovered new properties of imidazolium salts (IMSs), which suggest that they could play a vital role in disease prevention and treatment.

The report on the redox properties of IMSs was published in the Journal of the American Chemical Society.

In a separate study published in Angewandte Chemie International Edition, IBN researchers reported the first use of these salts to convert carbohydrates into versatile chemical compounds for biofuel production.

IBN researchers successfully used IMS to develop a new catalyst system for converting sugars into 5-hydroxymethylfurfural (HMF), a key compound used in biofuel chemistry and the petroleum industry.

In the Journal of the American Chemical Society, the IBN researchers described how they used IMSs to synthesize successfully uniform gold nanoparticles within seconds at room temperature. The ultrafine (1-2 nm) nanoparticles remained stable for up to 6 months at 4C.

Unlike conventional synthesis techniques using borane or borohydride reduction processes, IBN's method does not require a strong reducing reagent yet is able to produce gold nanoparticles under very mild reaction condition with remarkable efficiency.

IBN's new synthesis protocol could easily be scaled up for industrial applications.

Commonly used as solvents for various organic reactions, IMSs are room-temperature ionic liquids that are chemically stable and have low vapor pressure. While IMSs' physical properties have been widely studied, their biochemical properties and medical applications have seldom been mentioned in the scientific literature.

IBN Principal Research Scientist Yugen Zhang, Ph.D., said, "Our successful use of IMSs as a reducing agent led us to believe that we might also be able to use this compound as a radical scavenger antioxidant to counter the damage caused by re
'/>"/>

Contact: Cathy Yarbrough
sciencematter@yahoo.com
858-243-1814
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled Bipolar Trans Carotenoid Salts and Their Uses, for Its Family of First-In-Class Molecules
2. China Medicine Corporation Awarded GSP Certification
3. GeneNews to exhibit ColonSentry(TM) at Family Medicine Forum 2008
4. Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
5. MDV Expands Team Pursuing Advances in Personalized Medicine
6. Singapore Medicine - Singapore Doctors Use Hi-Tech Implant to Add Space to Narrowed Spinal Canals
7. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
10. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
11. RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to The Genome Center at Washington University School of Medicine in St. Louis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., Iceland, November 24 d...ed the approval of all of its,"first day" motions ...elaware,(the "Bankruptcy Court"). deCODE last week...er 11 of the United States Bankruptcy Code with th...y the Bankruptcy Court allow the company to contin...
(Date:11/24/2009)... /PRNewswire-Asia/ -- Shanghai Biolaxy announced t...FDA) has approved the,investigational new drug app...n), an innovative insulin formulation to treat dia...e its first phase I clinical study. , Dia...lucose and poor,metabolism. The complications of d...
(Date:11/24/2009)...point has been met for patients with advanced-stag...EC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna ...pany"), a global biopharmaceutical company focused...d positive efficacy data from a Phase 2 study with...8 (formerly AN-152), in patients with advanced or ...
(Date:11/24/2009)...09 Arena Pharmaceuticals... company is scheduled to present at the Piper Jaff... 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. Pac...k City. Jack Lief, Arena,s President and Chief Exe...w of the company, including its clinical developme...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...dia Site Live allows WVU to stream video from thei...an watch their classes from a computer at their co...l courses will be available on the web beginning t...need more nurse educators to teach the next genera...f nursing at WVU School of Nursing. By using Media...
...t only does WisconsinGuide.com save time, it has a...terson said that the site is a great example of re...to bring the real time economy to the traditional ...ners the ability to quickly, easily and affordably...nsinGuide.com was featured on the WMTV NBC 15 morn...
...e controversial May edition of the Harvard Busine... Nicholas Carr entitled IT Doesn,t Matter , questi...d a stir in the business and technology communitie... Marketing , a small company based in Appleton whi...d uses technology to impact the sales, marketing a...
Other Biology Technology:Sonic Foundry Facilitates Nursing Education 2Sonic Foundry Facilitates Nursing Education 3Wisconsin Tourism Aided by Internet Technology 2Wisconsin Tourism Aided by Internet Technology 3IT Does Matter! 2IT Does Matter! 3
(Date:11/26/2009)...countries has shown that closing schools in the ev... significant role in reducing illness transmission...BMC Infectious Diseases compared opportunities fo...finding that they were reduced when schools are sh...sity, Belgium, led a team of European researchers ...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
(Date:11/25/2009)...ives. In addition to mammalian immune systems that...d bacteriophages, viruses that kill half the bacte...and another class of microorganisms called archaea... deep-sea volcanic vents) manage just fine, thank ...system that helps protect them from many viruses a...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Ventilation After Breathing Tube Removal May Alter Outcomes 54416 1Ventilation After Breathing Tube Removal May Alter Outcomes 54416 2MRI May Not Improve Breast Cancer Outcome 54414 1China Medicine Announces Second Quarter 2009 Results 54412 1China Medicine Announces Second Quarter 2009 Results 54412 2China Medicine Announces Second Quarter 2009 Results 54412 3China Medicine Announces Second Quarter 2009 Results 54412 4China Medicine Announces Second Quarter 2009 Results 54412 5China Medicine Announces Second Quarter 2009 Results 54412 6China Medicine Announces Second Quarter 2009 Results 54412 7China Medicine Announces Second Quarter 2009 Results 54412 8China Medicine Announces Second Quarter 2009 Results 54412 9China Medicine Announces Second Quarter 2009 Results 54412 10China Medicine Announces Second Quarter 2009 Results 54412 11China Medicine Announces Second Quarter 2009 Results 54412 12China Medicine Announces Second Quarter 2009 Results 54412 13China Medicine Announces Second Quarter 2009 Results 54412 14
...lcohol spectrum disorder (FASD) and Fetal alcohol ...uding facial defects, short stature, and mental an...pus, is a valuable tool for understanding early ve..., easy to work with and very responsive to environ...ress the mechanism underlying the characteristics ...
...re,s Institute of Bioengineering and Nanotechnolog...oporous material using a unique surfactant templat... been predicted only mathematically (see reference... reference below), the IBN scientists report that ...h institute, is the first hexagonal nanoscale cons...
...LPHIA - A collaboration of University of Pennsylva...hesiologists have identified a fluorescent anesthe...ning more precise information about how anesthetic...e rapidly test new anesthetic compounds in the sea...dy is published online in the Proceedings of the ...
Other Biology News:Frogs reveal clues about the effects of alcohol during development 2First tri-continuous mesoporous Silica complex structure developed in Singapore 2Penn researchers demonstrate a new model for drug discovery with a fluorescent anesthetic 2Penn researchers demonstrate a new model for drug discovery with a fluorescent anesthetic 3
Rabbit Anti-GRASP1 Polyclonal Antibody, Unconjugated from Abcam
Porcine Galanin , 3-[125I]iodotyrosyl26 Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-HES1 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: